Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03828448 |
| Title | Study to Assess Umbralisib Plus Ublituximab in Patients With Treatment Naive Follicular Lymphoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | TG Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| TG Therapeutics Investigational Trial Site | Fort Myers | Florida | 33901 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Saint Petersburg | Florida | 33705 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Nashville | Tennessee | 37203 | United States | Details |